Case Report

Published on 04 Oct 2023

Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma

in Genitourinary Oncology

Caroline S. Jansen
Yujin Choi
Sean T. Evans
Rachel Greenwald
Joseph A. Behnke
Caitlin Hartman
Haydn Kissick
Lara R. Harik
Mehmet Asim Bilen

Frontiers in Oncology

doi 10.3389/fonc.2023.1271255

119 views

Original Research

Accepted on 03 Oct 2023

Association between radiotherapy and prognosis in patients with small cell carcinoma of the bladder undergoing bladder-sparing surgery

in Genitourinary Oncology

Fuchao Liang
Fei Zhou
Xiaoyuan Qian
Linghui Qin
Jiange Wang
Chen Ding
Yasen Kuniduzi
Xuejun Zhang
Lianming Fan

Frontiers in Oncology

doi 10.3389/fonc.2023.1275796

Case Report

Accepted on 03 Oct 2023

A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic TFE3-rearranged renal cell carcinoma：A Case Report

in Genitourinary Oncology

Haiyang Yang
Weidong Gan
Xiang Dong
Xinghe Pan
Wenliang Ma
Jun Pan
Hongqian Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1252282

Case Report

Published on 03 Oct 2023

Case Report: Resolution of high grade anal squamous intraepithelial lesion with antibiotics proposes a new role for syphilitic infection in potentiation of HPV-associated ASCC

in Genitourinary Oncology

A. Ranabhotu
N. Habibian
B. Patel
E. Farrell
J. Do
S. Sedghi
L. Sedghi

Frontiers in Oncology

doi 10.3389/fonc.2023.1226202

257 views

Systematic Review

Accepted on 02 Oct 2023

Imaging-Based Adipose Biomarkers for Predicting Clinical Outcomes of Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review

in Genitourinary Oncology

Xinyu Pei
Ye Xie
Yixuan Liu
Xinyang Cai
Lexuan Hong
Xiaofeng Yang
Luyao Zhang
Manhuai Zhang
Xinyi Zheng
Kang Ning

Frontiers in Oncology

doi 10.3389/fonc.2023.1198723

Original Research

Accepted on 02 Oct 2023

Magnetic Resonance Imaging Radiomics-Based Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions in the Transitional Zone

in Genitourinary Oncology

Ying-Ying Zhao
Mei-Lian Xiong
Li-Juan Duan
Jia-Li Chen
Yan-Shun Lin
Chen Tanhui
Zhen Xing

Frontiers in Oncology

doi 10.3389/fonc.2023.1247682

Case Report

Accepted on 02 Oct 2023

3D Laparoscopic Treatment of Bladder Cancer with Pelvic Multiorgan Invasion: A Case Report and Literature Review

in Genitourinary Oncology

Zheng Chen
Kaifeng Deng
Luping Sun
Lijun Qu
Xinhui Chao
Jingmin Rao
Caimmei Hong
Yu-Min Zhuo
Zhichao Lin
Caiyong Lai

Frontiers in Oncology

doi 10.3389/fonc.2023.1249389

Case Report

Accepted on 02 Oct 2023

Metastatic bladder cancer forming a sigmoidorectal fistula after enfortumab vedotin therapy: a case report

in Genitourinary Oncology

Shinji Tamada
Daiki Ikarashi
Naoki Yanagawa
Moe Toyoshima
Kenta Takahashi
Tomohiko Matsuura
Shigekatsu Maekawa
Renpei Kato
Mitsugu Kanehira
Ryo Takata

Frontiers in Oncology

doi 10.3389/fonc.2023.1274494

Brief Research Report

Published on 02 Oct 2023

Temporal changes in treatment patterns by age group and functional status before and after PD-1/L1 inhibitor approvals in advanced urothelial carcinoma

in Genitourinary Oncology

Gurjyot K. Doshi
Haojie Li
Mehmet Burcu
Srinivas Annavarapu
Karen Wells
Kentaro Imai
Blanca Homet Moreno
Puneet Singhal
Ronac Mamtani

Frontiers in Oncology

doi 10.3389/fonc.2023.1210208

398 views

Original Research

Accepted on 28 Sep 2023

Development and validation of a combined hypoxia-and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma

in Genitourinary Oncology

Xin Wu
Wenjie Xie
Binbin Gong
Bin Fu
Weimin Chen
Libo Zhou
Lianmin Luo

Frontiers in Oncology

doi 10.3389/fonc.2023.1162846

Clinical Trial

Accepted on 27 Sep 2023

Clinical study of renal artery cold perfusion combined with laparoscopic nephron retention in the treatment of complex renal angiomyolipoma

in Genitourinary Oncology

Chaoshuai Zhu
Yin Huaqi
Shiming Zhao
yongkang Ma
Zhenghui Sun
Mingkai Zhu
Du Zheng
Tiejun Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1220380

Case Report

Published on 27 Sep 2023

The second docetaxel rechallenge for metastatic castration-resistant prostate cancer: a case report

in Genitourinary Oncology

Wei Ning
Pengkang Chang
Ji Zheng
Fan He

Frontiers in Oncology

doi 10.3389/fonc.2023.1185530

501 views

Review

Published on 27 Sep 2023

Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews

in Genitourinary Oncology

Darren Leaning
Gagandeep Kaur
Alicia K. Morgans
Ray Ghouse
Osvaldo Mirante
Simon Chowdhury

Frontiers in Oncology

doi 10.3389/fonc.2023.1240864

639 views

Original Research

Accepted on 26 Sep 2023

Clinicopathological and Molecular Analysis of Microsatellite Instability in Prostate Cancer: A Multi-Institutional Study in China

in Genitourinary Oncology

Huizhi Zhang
Xiaoqun Yang
Jialing Xie
Xiao Cheng
Jiayi Chen
Miaomiao Shen
Wenyi Ding
Suying Wang
Zhe Zhang
Chaofu Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1277233

Original Research

Accepted on 25 Sep 2023

Establishment and Validation of a Nomogram to Select Patients with Metastatic Sarcomatoid Renal Cell Carcinoma Suitable for Cytoreductive Radical Nephrectomy

in Genitourinary Oncology

Yulin Zhou
Conghui Han
Jingping Ge
Le Qu
Chaopeng Tang
Yufeng Gu
Jie Dong
Song Xu
Zhengcheng Sheng
Xiaodong Zhao

Frontiers in Oncology

doi 10.3389/fonc.2023.1239405

Perspective

Accepted on 25 Sep 2023

Improving the identification of high-risk non-metastatic castrationresistant prostate cancer patients in clinical practice

in Genitourinary Oncology

Alina Rosinha
Carlos Rabaça
Fernando Calais
João Moreira Pinto
João Vasco Barreira
Ricardo Fernandes
Rodrigo Ramos
Ana Cristina Fialho
José Palma dos Reis

Frontiers in Oncology

doi 10.3389/fonc.2023.1266369

Navigation group

Articles

Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma

Association between radiotherapy and prognosis in patients with small cell carcinoma of the bladder undergoing bladder-sparing surgery

A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic TFE3-rearranged renal cell carcinoma：A Case Report

Case Report: Resolution of high grade anal squamous intraepithelial lesion with antibiotics proposes a new role for syphilitic infection in potentiation of HPV-associated ASCC

Imaging-Based Adipose Biomarkers for Predicting Clinical Outcomes of Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review

Magnetic Resonance Imaging Radiomics-Based Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions in the Transitional Zone

3D Laparoscopic Treatment of Bladder Cancer with Pelvic Multiorgan Invasion: A Case Report and Literature Review

Metastatic bladder cancer forming a sigmoidorectal fistula after enfortumab vedotin therapy: a case report

Temporal changes in treatment patterns by age group and functional status before and after PD-1/L1 inhibitor approvals in advanced urothelial carcinoma

Development and validation of a combined hypoxia-and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma

Clinical study of renal artery cold perfusion combined with laparoscopic nephron retention in the treatment of complex renal angiomyolipoma

The second docetaxel rechallenge for metastatic castration-resistant prostate cancer: a case report

Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews

Clinicopathological and Molecular Analysis of Microsatellite Instability in Prostate Cancer: A Multi-Institutional Study in China

Establishment and Validation of a Nomogram to Select Patients with Metastatic Sarcomatoid Renal Cell Carcinoma Suitable for Cytoreductive Radical Nephrectomy

Improving the identification of high-risk non-metastatic castrationresistant prostate cancer patients in clinical practice